BioMérieux Recalls VITEK 2 Compact 30 Software and Reagent Cards
BioMérieux is recalling VITEK 2 Compact 30 software and reagent cards because a software update prevents test cards from finalizing results, potentially disrupting laboratory processing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a temporary or medically reversible adverse health consequence. However, the specific hazard described is a software malfunction that prevents test finalization rather than a direct physical injury or high-risk pathogen exposure, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
BioMérieux Inc is recalling 9,234 units of VITEK 2 Compact 30 software and reagent cards, including reference numbers 27530, 27530R, 27630, and 17630R. These products are designed for the identification and antimicrobial susceptibility testing of bacteria and yeast. The recall affects VITEK 2 Compact 15 and Compact 30 instruments that were previously manufactured or installed with VITEK 2 System software versions prior to 5.01 and are currently being upgraded to version 8.01.
The recall was initiated after customers reported that some VITEK 2 cards remain in a preliminary status and do not finalize after being ejected from the instrument. This issue prevents cards in subsequent carousel slots from being processed. The problem was reported to occur on VITEK 2 Compact 15 and Compact 30 systems following the system software update to version 8.01.
The affected products were distributed worldwide. Users of these systems should contact BioMérieux Inc for further instructions regarding the software update and potential workarounds to ensure proper processing of test cards.
The recalled product
- Product
- VITEK¿ 2 Compact 30, REF numbers: 27530 and 27530R (clinical), and 27630 and 17630R (industry) software and reagent cards designed for the identification (ID) and antimicrobial susceptibility testing (AST) of bacteria and yeast.
- Manufacturer
- Biomerieux Inc
- Affected units
- 9,234
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- and currently being upgraded to version 8.01.
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 2 recalled by Biomerieux Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Biomerieux Inc
See all →- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighSusceptibility test cards recalled over false resistant antibiotic results
FDA (Devices) · 2026-02-11
- HighAntimicrobial susceptibility test cards recalled over false colistin resistance results
FDA (Devices) · 2025-10-08
- SevereVITEK 2 AST Test Kits: Ceftriaxone Concentration Error Risk
FDA (Devices) · 2024-05-01
- HighMedical Device Middleware: MYLA Software Fails to Apply AST Filter Rules
FDA (Devices) · 2023-03-08
Same hazard · software malfunction
See all →- HighAbbott Merlin pacemaker programmer may fail to terminate threshold test
FDA (Devices) · 2026-06-17
- HighMedtronic SynchroMed Flex Infusion Programmer Software Application
FDA (Devices) · 2026-05-20
- ModerateProtocol Configuration Tool software v1.3.0 for Hamilton AutoLys STAR
FDA (Devices) · 2026-04-29
- ModerateChange Healthcare Cardiology Hemo Software Unexpected Shutdown Risk
FDA (Devices) · 2025-07-09
- HighSiemens Interventional Fluoroscopic X-Ray System Software Communication Failure
FDA (Devices) · 2025-07-09